Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Ferumoxytol-enhanced MRI shows potential for neuroimaging of patients with HAND

April 8, 2013

Stribild combination tablets approved in Japan

April 3, 2013

Bristol-Myers Squibb presents new series of anti-HIV agents

March 27, 2013

Small-molecule antiviral agents target HIV-1 replication

March 27, 2013

Stribild gets positive opinion in Europe

March 25, 2013

Biotron announces preliminary results from human trial of BIT-225

March 21, 2013

Novel potent maturation inhibitors developed by DFH Pharma

March 14, 2013

KM-023 demonstrates good tolerance and pharmacokinetics in a phase I trial

March 8, 2013

VAC-3S immunotherapeutic proves safe and well tolerated in HIV-1

March 8, 2013

MK-1439 shows good safety and efficacy in previously untreated HIV-infected patients

March 7, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...